Multiplex Assays Market Research Report – Forecast to 2027

Multiplex Assays Market: By Products and Services (Consumables, Instruments), Types (Protein & Nucleic Acid Assay), Technology (Flow Cytometry & Other Technology), Application (Clinical Diagnostic), End-User (Hospital)– Forecast Till 2027

ID: MRFR/HC/4677-HCR | February 2021 | Region: Global | 90 pages

Multiplex Assays Market Scenario


The multiplex assays market is expected to reach an approximate CAGR of 7.8% during the forecast period. An assay which simultaneously measures multiple analysts in a single cycle is known as a multiplex assay. Technological advancement is one of the driving factors for the growth of this market. The rapid development in nanotechnology has taken this to the next level of nanoarray, which represents the ultra-miniaturization version of the conventional microarray. Increasing awareness about the multifactorial nature of various diseases and pathological conditions such as cancer and Alzheimer disease has created a requirement to produce a cost-effective and time-saving measurement of multiple analysts in a single sample. This factor drives the multiplex assays market.


Reproducibility crisis and complex clinical trial procedures for multiplex assay products are limiting the growth of the market.


Segmentation


The multiplex assays market is segmented on the basis of products and services, types, technology, application, and end-user. On the basis of products and services, the multiplex assays market is segmented into consumable, instrument, and software and services. Based on types, the market is segmented into protein, nucleic acid, and cell-based multiplex assay. Further, protein multiplex assay is sub-segmented into planer protein assay and bead-based protein assay. Nucleic acid multiplex assay is further sub-segmented into planer nucleic acid assay, bead-based nucleic acid assay, and other nucleic acid assay. On the basis of technology, the multiplex assay market is further segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies. Further on the basis of application, the market is segmented into research and development, clinical diagnostic, and other diseases. Research and development is further sub-segmented into drug discovery and development, biomarker discovery, and validation. Clinical diagnostic is further sub-segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and other diseases. Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, hospital and research institutes, clinical laboratories, and other end-users.


Key players


Some of the key players in the multiplex assays market are Thermo Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc, BD, Merck Sharp & Dohme Corp, Agilent Technologies, Meso Scale Diagnostics LLC, Randox Laboratories Ltd,  Quanterix, Bio-Techne, and  Seegene Inc.


Regional Market Summary


Global Multiplex Assays Market Share (%), by Region, 2018


Multiplex Assay  Market Share


Sources: National Electronic Health Records Survey, U.S. Department of Health & Human Services, National Centre for Health Statistics


The multiplex assays market is divided into four major regions, namely, North America, Europe, Asia-Pacific, and the rest of the world. North America accounts for the largest share of the multiplex assays market owing to strong R&D activities in this region. The US is a leading country in biopharmaceutical research and development. The key factors that drive the growth of the market in this region are increase in patient population, the rise in the prevalence of Alzheimer disease, and a significant rise in research and development activities in pharmaceutical companies for the treatment of diseases such as cancer and Alzheimer.  


Asia-Pacific is expected to register the highest CAGR during the forecast period. Factors influencing the growth of this region include increasing geriatric population, rising prevalence of cataract, and increasing prevalence of Alzheimer disease in this region.


The European region is projected to register the highest CAGR during the forecast period due to increasing geriatric population included in system illness and chronic infection.


The Middle East and Africa holds the least share in the global multiplex assay market due to the presence of stringent government policies and poor economies.


Market Segmentation and Key Market Players


Multiplex Assays Market, by Products & Services



  • Consumable

  • Instrument

  • Software & Services


Multiplex Assays market, by Type



  • Protein multiplex assay

  • Planer protein assay

  • Bead-based protein assay

  • Nucleic acid multiplex assay

  • Planer nucleic acid assay

  • Bead-based nucleic acid assay

  • Other nucleic acid assay

  • Cell-based multiplex assay


Multiplex Assays Market, by Technology



  • Flow cytometry

  • Fluorescence detection

  • Luminescence

  • Multiplex real-time PCR

  • Other technology


Multiplex Assays Market, by Application



  • Research & development

  • Drug discovery & development

  • Biomarker discovery & validation

  • Clinical diagnostic

  • Infectious disease

  • Cancer

  • Cardiovascular disease

  • Autoimmune disease

  • Nervous system disorders

  • Other diseases


Multiplex Assays Market, by End-User



  • Pharmaceutical and biotechnology companies

  • Hospitals

  • Research institutes

  • Clinical laboratories

  • Other end-users


Multiplex Assays Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Multiplex Assays Market, by Key Players



  • Thermo Fisher Scientific Inc

  • Illumina Inc

  • Bio-Rad Laboratories Inc

  • Qiagen

  • Abcam plc

  • BD

  • Merck Sharp & Dohme Corp

  • Agilent Technologies

  • Meso Scale Diagnostics LLC

  • Randox Laboratories Ltd

  • Quanterix,

  • Bio-Techne

  • Seegene Inc.


Intended Audience



  • Biotechnology company

  • Pharmaceutical company

  • Government & private laboratories

  • Research & development companies

  • Medical research laboratories



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.8% (2018-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Products and Services, Types, Technology, Application and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc, BD, Merck Sharp & Dohme Corp, Agilent Technologies, Meso Scale Diagnostics LLC, Randox Laboratories Ltd, Quanterix, Bio-Techne, and Seegene Inc.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Technological advancement
  • Increasing awareness about the multifactorial nature of various diseases


  • Table of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Multiplex Assay Market, by Products & Services

    6.1 Introduction

    6.2 Consumable

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Instrument

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Software & Services

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Multiplex Assay Market, by Types

    7.1 Introduction

    7.2 Protein Multiplex Assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.2.1 Planer protein assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.2.2 Bead-based protein assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Nucleic Acid Multiplex Assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3.1 Planer nucleic acid assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3.2 Bead-based nucleic acid assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3.2 Other nucleic acid assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Cell-based multiplex assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Multiplex Assay Market, by Application

    8.1 Introduction

    8.2 Research & development

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.2.1 Drug discovery & development

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.2.2 Biomarker discovery & validation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Clinical diagnostic

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3.1 Infectious disease

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3.2 Cancer

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3.3 Cardiovascular disease

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3.4 Autoimmune disease

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3.5 Nervous system disorders

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Multiplex Assay Market, by End-User

    9.1 Pharmaceutical and biotechnology companies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.2 Hospital & Research Institute

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Clinical laboratories

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Other End-User

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 10. Global Multiplex Assay Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 US

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia-Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 South Korea

    10.4.6 Rest of Asia-Pacific

    10.5 Middle East & Africa

    10.5.1 Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Thermo Fisher Scientific Inc

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Illumina Inc

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Bio Rad Laboratories Inc

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Qiagen

    12.4.1 Company Overview

    12.4.2 Technology/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Abcam plc

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 BD

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Merck Sharp & Dohme Corp

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Agilent Technologies

    12.8.1 Overview

    12.8.2 Product/ Technology Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Meso Scale Diagnostics LLC

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Randox Laboratories Ltd

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12. 11 Quanterix

    12. 11.1 Overview

    12. 11.2 Product Overview

    12. 11.3 Financials

    12. 11.4 Key Developments

    12. 11.5 SWOT Analysis

    12.12 Bio-Techne

    12.12.1 Overview

    12.12.2 Product Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    12.13 Seegene Inc

    13.13.1 Overview

    13.13.2 Product Overview

    13.13.3 Financials

    13.13.4 Key Developments

    13.13.5 SWOT Analysis

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s Viewpoint

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Predictions for the Multiplex Assay Industry

    Chapter 14. Appendix

    LIST OF TABLES

    Table 1 Global Multiplex Assay Market Synopsis, 2020-2027

    Table 2 Global Multiplex Assay Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Multiplex Assay Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

    Table 5 Global Multiplex Assay Market, by Types, 2020-2027 (USD Million

    Table 6 Global Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

    Table 7 Global Multiplex Assay Market, by Application, 2020-2027 (USD Million)

    Table 8 North America: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

    Million)

    Table 9 North America: Multiplex Assay Market, by Types, 2020-2027 (USD

    Million)

    Table 10 North America: Multiplex Assay Market, by End-User, 2020-2027 (USD

    Million)

    Table 11 North America: Multiplex Assay Market, by Application, 2020-2027 (USD

    Million)

    Table 12 US: Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

    Table 13 US: Multiplex Assay Market, by Types, 2020-2027 (USD Million)

    Table 14 US: Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

    Table 15 US: Multiplex Assay Market, by Application, 2020-2027 (USD Million)

    Table 16 Canada: Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

    Table 17 Canada: Multiplex Assay Market, by Types, 2020-2027 (USD Million)

    Table 18 Canada: Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

    Table 19 Canada: Multiplex Assay Market, by Application, 2020-2027 (USD

    Million)

    Table 20 South America: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

    Million)

    Table 21 South America: Multiplex Assay Market, by Types, 2020-2027 (USD

    Million)

    Table 22 South America: Multiplex Assay Market, by End-User, 2020-2027 (USD

    Million)

    Table 23 South America: Multiplex Assay Market, by Application, 2020-2027 (USD

    Million)

    Table 24 Europe: Multiplex Assay Market, by Products & Services, 2020-2027 (USD Million)

    Table 25 Europe: Multiplex Assay Market, by Types, 2020-2027 (USD Million)

    Table 26 Europe: Multiplex Assay Market, by End-User, 2020-2027 (USD Million)

    Table 27 Europe: Multiplex Assay Market, by Application, 2020-2027 (USD Million)

    Table 28 Western Europe: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

    Million)

    Table 29 Western Europe: Multiplex Assay Market, by Types, 2020-2027 (USD

    Million)

    Table 30 Western Europe: Multiplex Assay Market, by End-User, 2020-2027 (USD

    Million)

    Table 31 Western Europe: Multiplex Assay Market, by Application, 2020-2027

    (USD Million)

    Table 32 Eastern Europe: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

    Million)

    Table 33 Eastern Europe: Multiplex Assay Market, by Types, 2020-2027 (USD

    Million)

    Table 34 Eastern Europe: Multiplex Assay Market, by End-User, 2020-2027 (USD

    Million)

    Table 35 Eastern Europe: Multiplex Assay Market, by Application, 2020-2027

    (USD Million)

    Table 36 Asia-Pacific: Multiplex Assay Market, by Products & Services, 2020-2027 (USD

    Million)

    Table 37 Asia-Pacific: Multiplex Assay Market, by Types, 2020-2027 (USD

    Million)

    Table 38 Asia-Pacific: Multiplex Assay Market, by End-User, 2020-2027 (USD

    Million)

    Table 39 Asia-Pacific: Multiplex Assay Market, by Application, 2020-2027 (USD

    Million)

    Table 40 Middle East & Africa: Multiplex Assay Market, by Products & Services, 2020-2027

    (USD Million)

    Table 41 Middle East & Africa: Multiplex Assay Market, by Types, 2020-2027

    (USD Million)

    Table 42 Middle East & Africa: Multiplex Assay Market, by End-User, 2020-2027

    (USD Million)

    Table 43 Middle East & Africa: Multiplex Assay Market, by Application, 2020-2027

    (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Multiplex Assay Market

    Figure 3 Segmentation Market Dynamics for Global Multiplex Assay Market

    Figure 4 Global Multiplex Assay Market Share, by Products & Services, 2020

    Figure 4 Global Multiplex Assay Market Share, by Types, 2020

    Figure 5 Global Multiplex Assay Market Share, by End-User, 2020

    Figure 6 Global Multiplex Assay Market Share, by Application, 2020

    Figure 7 Global Multiplex Assay Market Share, by Region, 2020

    Figure 8 North America: Multiplex Assay Market Share, by Country, 2020

    Figure 9 Europe: Multiplex Assay Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Multiplex Assay Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Multiplex Assay Market Share, by Country, 2020

    Figure 12 Global Multiplex Assay Market: Company Share Analysis, 2020 (%)

    Figure 13 Thermo Fisher Scientific Inc.: Key Financials

    Figure 14 Thermo Fisher Scientific Inc.: Segmental Revenue

    Figure 15 Thermo Fisher Scientific Inc.: Geographical Revenue

    Figure 16 Illumina Inc.: Key Financials

    Figure 17 Illumina Inc.: Segmental Revenue

    Figure 18 Illumina Inc.: Geographical Revenue

    Figure 19 Bio Rad Laboratories Inc: Key Financials

    Figure 20 Bio Rad Laboratories Inc.: Segmental Revenue

    Figure 21 Bio Rad Laboratories Inc.: Geographical Revenue

    Figure 22 Qiagen: Key Financials

    Figure 23 Qiagen: Segmental Revenue

    Figure 24 Qiagen: Geographical Revenue

    Figure 25 Abcam plc: Key Financials

    Figure 26 Abcam plc: Segmental Revenue

    Figure 27 Abcam plc: Geographical Revenue

    Figure 28 BD: Key Financials

    Figure 29 BD: Segmental Revenue

    Figure 30 BD: Geographical Revenue

    Figure 31 Merck Sharp & Dohme Corp: Key Financials

    Figure 32 Merck Sharp & Dohme Corp: Segmental Revenue

    Figure 33 Merck Sharp & Dohme Corp: Geographical Revenue

    Figure 34 Agilent Technologies: Key Financials

    Figure 35 Agilent Technologies: Segmental Revenue

    Figure 36 Agilent Technologies: Geographical Revenue

    Figure 37 Meso Scale Diagnostics LLC: Key Financials

    Figure 38 Meso Scale Diagnostics LLC: Segmental Revenue

    Figure 39 Meso Scale Diagnostics LLC: Geographical Revenue

    Figure 40 Randox Laboratories Ltd: Key Financials

    Figure 41 Randox Laboratories Ltd: Segmental Revenue

    Figure 42 Randox Laboratories Ltd: Geographical Revenue

    Figure 43 Quanterix: Key Financials

    Figure 44 Quanterix: Segmental Revenue

    Figure 45 Quanterix: Geographical Revenue

    Figure 46 Bio-Techne: Key Financials

    Figure 47 Bio-Techne: Segmental Revenue

    Figure 48 Bio-Techne: Geographical Revenue

    Figure 49 Seegene Inc: Key Financials

    Figure 50 Seegene Inc: Segmental Revenue

    Figure 51 Seegene Inc: Geographical Revenue



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.